Insider Shareholders with Direct Ownership of Rocket Pharmaceuticals, Inc. (RCKT)
This section provides a comprehensive overview of the insiders with direct ownership of Rocket Pharmaceuticals, Inc. (RCKT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ROCKET PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gaurav Shah
CEO |
289,802 | 329,693 | 707,328 $8.26 Million | 20 |
Nov 21, 2024
Reduced 1.54%
|
| 278,143 | 39,380 | 392,395 $4.58 Million | 17 |
Nov 21, 2024
Reduced 1.16%
|
|
| 99,624 | 193,124 | 114,784 $1.34 Million | 5 |
Apr 15, 2024
Reduced 8.01%
|
|
| 224,529 | 48,557 | 94,546 $1.1 Million | 3 |
Feb 17, 2023
Reduced 3.63%
|
|
| 87,758 | 18,638 | 69,140 $807,555 | 5 |
Oct 31, 2024
Reduced 4.26%
|
|
|
Martin Wilson
General Counsel |
64,774 | 20,638 | 63,560 $742,380 | 10 |
Nov 21, 2024
Reduced 1.82%
|
| 72,519 | 27,547 | 49,310 $575,940 | 29 |
Nov 21, 2024
Reduced 2.42%
|
|
|
Aaron Ondrey
Chief Financial Officer |
46,781 | 0 | 46,781 $546,402 | 1 |
Apr 01, 2024
Added 50.0%
|